Public2.xls

Geneva General Hospital
HEART ATTACK
National Mayo
PERFORMANCE MEASURE
ANGINA & HEART ATTACK CARE
Angina is a disease marked by brief attacks of chest pain caused by a lack of oxygen to the heart. A heart attack occurs when blood flow into the heart is interrupted.
% of eligible patients receiving aspirin at arrival to the hospital to help prevent clotting and restore blood flow to the heart % of eligible patients prescribed aspirin at discharge as a preventive % of eligible patients prescribed beta blocker medication at discharge from % of eligible patients with left ventricular systolic dysfunction (inability of the heart to pump blood effectively) who are prescribed ACE inhibitors or Angiotensin Receptor Blocker to help lower blood pressure and prevent future heart attacks or had contraindication to ACE or ARB documented * Data source Thomson Reuters* National Average and Mayo Clinic are from CMS (Jan 2009 - Dec 2009)* N/A no patients to measure for timeframe Geneva General Hospital
HEART FAILURE
National Mayo
PERFORMANCE MEASURE
% of eligible patients with left ventricular systolic dysfunction (inability of the heart to pump blood effectively) who are prescribed ACE inhibitors or Angiotensin Receptor Blocker to help lower blood pressure and prevent future heart attacks or had contraindication to ACE or ARB documented % of smokers who received smoking cessation advice or medication such 100.0%
Appropriate Discharge Instructions* Data source Thomson Reuters* National Average and Mayo Clinic are from CMS (Jan 2009 - Dec 2009) Geneva General Hospital
PNEUMONIA
National Mayo
PERFORMANCE MEASURE
BLOOD CULTURES
A blood culture is a test for presence of bacteria in the blood.
% of patients who receive a blood culture before antibiotics are given ANTIBIOTIC TIMING
Antibiotics are generally given as soon as appropriate to pneumonia patients to speed recovery.
% of patients who receive antibiotics within six hours of hospital arrival PNEUMOCOCCAL VACCINATION
% of pneumonia patients 65 years and older who were screened and vaccinated to decrease the likelihood of pneumonia INFLUENZA VACCINATION
% of patients who were screened and vaccinated to decrease the * Data source Thomson Reuters* National Average and Mayo Clinic are from CMS (Jan 2009 - Dec 2009) Geneva General Hospital
STROKE MEASURES
National
PERFORMANCE MEASURE
MEDICATION MANAGEMENT
Typically, only a small number of patients arrive at the hospital in time to get clot buster medication. Manageing risk factors onpreventing stroke as a greatest impact.
% of stroke patients who arrive at the Emergency Center within two hours of onset of symptoms who were assessed for clot buster medication (t-PA) to % of stroke or TIA patients placed on clot preventing medications, such as warfarin, aspirin, or other antiplatelet drugs by hospital day 2 % of stroke or TIA patients with atrial fibrillation discharged on anticoagulation therapy (coumadin) unless a contraindication exists BLOOD CLOT PREVENTION
% of patients at risk for blood clots in their legs who received preventive STROKE PREVENTION
These are the key factors that are important in managing risk factors to prevent stroke % of stroke or TIA patients Receiving appropriate education % of smokers who received smoking cessation advice or medication such as * Data source Outcome* National Averages from Outcomes 4Q2009

Source: http://flrhs.org/documents/quality/GGH-06-11.pdf

08 informatie over hoogteziekte_download_220908

Bij het beklimmen van de Kilimanjaro (hoogte 5.895 meter) of Mount Meru (hoogte 4.566 meter) is het goed om te weten wat acute hoogteziekte is, waardoor het ontstaat, hoe je de symptomen kan herkennen en welke maatregelen genomen moeten worden als het zich voordoet. De beklimming van de Kilimanjaro of Mount Meru gebeurd onder leiding van een gids. Het zijn erkende gidsen die kennis hebben van ho

Swiss line launches revolutonary anti-aging product –

SWISS LINE CELL SHOCK AGE INTELLIGENCE YOUTH-INDUCING SYSTEM A New Era of Molecular Skincare The Domino Effect of Knocking Down the Signs of Ageing 9 September 2013, Kuala Lumpur – Swiss line in its latest attempt to deliver the most advance anti-aging solution has produced another extraordinary outcome. Swiss line’s cutting-edge research and development has produced not just

© 2010-2018 Modern Medicine